Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Trial

Autor: L. Kvill, S. Ball, R. Harrington, Jack E. Smith, A. Kristinsson, David J. Moliterno, James E. Tcheng, D. Marcantuono, M. Goeres, Stephen G. Ellis, K. Finnie, T. Nygaard, M. Senaratne, G. Carreon, John F. Seaworth, Manjushri Bhapkar, John H. Alexander, J. Diodati, Kathleen M. Trollinger, E. Luiden, Cynthia Binanay, D. Debowey, G. Strand, A. Rames, M. Dorsey, A. Prosser, F. Van de Werf, J. Becker, C. Morgan, N. Kohler, K. Tinnin, Lee W. Jones, K. Andreatta, S. McCreery, N. Bhalodkar, P. Greenwood, T. Ivanc, B. Spinogatti, A. Paraschos, B. Steiner, Cynthia L. Green, S. Roth, S. Nallcy, N. McIntosh-Yellin, Brian S. Crenshaw, W. Hui, A. Valeria, M. Edwards, William B. Hillegass, M. Peek, E. Shalit, Barbara E. Tardiff, A. B. Chandler, Mitchell W. Krucoff, J. Jensen, H. Plardardottir, Richard C. Becker, A. Michael Lincoff, J. K. White, Joseph A. Puma, T. Nielsen, L. Paraschos, K. Feskiw, G. Oddsson, Eric J. Topol, V. Runarsdottir, Robert A. Harrington, Keith H. Newby, B. Potkin, K. Quintero, P. Desantis, Eric R. Bates, A. Luyten, K. Lerrick, John M. Burks, W. Sutherland, T. Johnson, J. Parker, Robert M. Califf, Paul W. Armstrong, James P. White, M. Bokslag

Publikováno v: Journal of the American College of Cardiology. 32:2003-2010

The trial was designed to assess the safety, pharmacodynamics and effects on reperfusion of the platelet glycoprotein (GP) IIb/IIIa inhibitor lamifiban when given with thrombolysis to patients with ST segment elevation acute myocardial infarction.Stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::681db670f8863899f349ca8de52c973a
https://doi.org/10.1016/s0735-1097(98)00474-4